检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Efficacy and safety of zenocutuzumab, a HER2 x HER3 bispecific antibody, across advanced NRG1 fusion (NRG1+) cancers.

Alison M. Schram,Koichi Goto,Dong-Wan Kim,Patricia Martin-Romano,Sai-Hong Ignatius Ou,Grainne M. O'Kane,Eileen Mary O'Reilly, Kumiko Umemoto,Michael Duruisseaux,Cindy Neuzillet,Frans Opdam,Jordi Rodon Ahnert,Misako Nagasaka,Benjamin Adam Weinberg,Teresa Macarulla,Andrew K. Joe,Jim Ford,Viktoriya Stalbovskaya, Ernesto Wasserman,Alexander E. Drilon

JOURNAL OF CLINICAL ONCOLOGY（2022）

引用 12|浏览4
暂无评分
关键词
bispecific antibody,zenocutuzumab,advanced nrg1 fusion,cancers
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要